0001209191-23-048967.txt : 20230911
0001209191-23-048967.hdr.sgml : 20230911
20230911173350
ACCESSION NUMBER: 0001209191-23-048967
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230911
DATE AS OF CHANGE: 20230911
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: van der Horst Edward
CENTRAL INDEX KEY: 0001957499
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39980
FILM NUMBER: 231248567
MAIL ADDRESS:
STREET 1: C/O SENSEI BIOTHERAPEUTICS, INC.
STREET 2: 451 D STREET, SUITE 710
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sensei Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001829802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1405 RESEARCH BLVD, SUITE 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
BUSINESS PHONE: (240) 243-8000
MAIL ADDRESS:
STREET 1: 1405 RESEARCH BLVD, SUITE 125
CITY: ROCKVILLE
STATE: MD
ZIP: 20850
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-02-15
0
0001829802
Sensei Biotherapeutics, Inc.
SNSE
0001957499
van der Horst Edward
C/O SENSEI BIOTHERAPEUTICS, INC.
1405 RESEARCH BLVD, SUITE 125
ROCKVILLE
MD
20850
0
1
0
0
Chief Scientific Officer
0
Common Stock
2023-02-15
4
F
0
9525
1.50
D
52913
D
Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.
/s/ Mark Ballantyne, Attorney-in-Fact
2023-09-11